The 2013 French American Innovation Day (FAID)


USA and France will analyse and enhance innovation in Life Sciences as an economic force for growth

- December 5th and 6th, 2013 -

The French American Innovation Day (FAID) is the flagship seminar of the Office of Science and Technology of the French Embassy in the U.S., Boston section. Focused on innovation in life sciences, the 2013 edition of the FAID will address how investment and initiatives in this sector may lead to the overall growth, expansion, and recovery of the economy for the benefit of patients. It will explore the novel ways of ensuring efficient collaboration that are emerging, mostly driven by the concept of open innovation based on cooperation and sharing between partners. It will take place at the Joseph B. Martin Conference Center at Harvard Medical School located at 77 Avenue Louis Pasteur in Boston, Massachusetts 02115, on December 5th and 6th, 2013. This event is open to and welcomes both corporations and academia.

Bearing the title “Innovation in Life Sciences as a Driver for Growth” , the seminar breaks down into 2 days:

  • The first day with four thought-provoking roundtable sessions, each addressing relevant issues and sharing best practices in life sciences innovation and transatlantic partnerships ;
  • The second day will be dedicated to presentations of innovative American and French start up companies to the financial and biopharmaceutical communities for funding and collaboration;
    with the help of two accomplished scientific directors,
  • Dr. Christophe Benoist, Professor of Microbiology and Immunology at Harvard Medical School, Member of the French Académie des Sciences and the US National Academy of Sciences
  • Dr. Joshua Boger, founder of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and the Executive Chairman of Alkeus Pharmaceuticals

    The 2013 FAID is designed by and for the stakeholders in R&D, technology transfer, strategic alliances and funding/venturing in Life Sciences from both countries. This event is open to and welcomes both corporations and academia.

    It will take place at the :

    Joseph B. Martin Conference Center at Harvard Medical School

    77 Avenue Louis Pasteur

    Boston, MA 02115


    The event is co-sponsored by Inserm (Institut National de la Santé et de la Recherche Médicale), Inserm Transfert, Inserm Transfert Initiative, and the Office of Science & Technology of the French Embassy in the USA.

    For more information and registration, please visit our website:

    - Partners

Founded in 1964 the French National Institute of Health and Medical Research (INSERM) is the only public French science and technological institute dedicated to biological and medical research to improve human health, boasting over 15,000 researchers, engineers, and technicians. Operating under the joint authority of the French Ministry of Health and the French Ministry of Research, INSERM took on the responsibility for the strategic, scientific, and operational coordination of biomedical research. INSERM distinguishes itself by being able to lead a multi-thematic approach to human conditions, guiding the healing and treatment processes from the research laboratories to patients’ bedsides, fostering an intimate understanding of both the most frequent and rarest of human ailments. INSERM is also a member of AVIESAN (The National Alliance of Health and Life Sciences) created in 2009, which groups together the prestigious French organizations and establishments including CEA, CNRS, CHRU, CPU, INRA, INRIA, INSTITUT PASTEUR, and IRD.

More information can be found at

Founded in 2000, InsermTransfert SA is the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), dedicated to technology transfer (from invention disclosure to industrial partnership). Inserm Transfert also manages European and International research projects, supports large scale projects in epidemiology and public health. Inserm Transfert runs a 2M€/year proof of concept fund. The company also supports entrepreneurs in the biotech sector, in partnership with Inserm Transfert Initiative, a € 39.7m life sciences seed investment company.

Inserm Transfert Initiative is a seed-capital company that has raised €35.5 million in new funding in 2012. It focuses on providing seed capital for innovative young companies in the biomedical field. Inserm Transfert Initiative was created in 2005 through an equal partnership between four providers of finance to biotech start-ups: Inserm Transfert SA, CDCEntreprises, Natexis Venture Selection and Sofinnova Partners. Inserm Transfert Initiative supports biotech entrepreneurs in the early stages of their companies’ development.

- Practical Information

FAID 2013 will take place at the Joseph B. Martin Conference Center at Harvard Medical School located at 77 Avenue Louis Pasteur in Boston, Massachusetts 02115, on December 5th and 6th, 2013. The Program will extend from 8:30 AM to 2:15 PM on December 5th, and from 8:30 AM to 1:00 PM December 6th

No admission fee is charged to the attendees, but registration is mandatory.

- Contact:

Dr. Jean-Jacques YARMOFF
Attaché for Science and Technology
Phone: (617) 832-4464

Deputy Science Attaché - Biotechnology & Technology Transfer
Phone: (617) 832-4468

- About the FAID

The FAID is an annual Franco-American event gathering scientists, industrialists and investors in highly specialized scientific fields. Its goals are to showcase the scientific and technological advantages of France to the United States, and also to develop collaborations between laboratories and companies.

- About the Office for Science and Technology of the Embassy of France in U.S.A. (OST)

Innovation is the main economic driving force of the New England economy, and many indicators testify of this vitality: Massachusetts stands among the six leading states, as far as new technologies and innovation are concerned. The excellence of research that is performed in universities, as well as the ambitious public programs designed to support the development of new technologies, and a dynamic community of investors and entrepreneurs, are the ferments of New England’s economic success. France also deserves its reputation as one of the world’s leading countries in terms of research and academic excellence, which explains the importance of our cooperation with New England.

The Office for Science and Technology’s mission consists in fostering cooperation between companies, entrepreneurs and actors of research and technology transfer on both sides of the Atlantic, and in supporting initiatives that facilitate collaborations in research and innovation.

For more information visit or contact us!

Last modified on 13/11/2013

top of the page